Author | Johanna Bendell, MD | OncLive

Author | Johanna Bendell, MD

Articles

Dr. Bendell Discusses a Phase III Study of Apatinib in Gastric Cancer

June 28, 2014

Video

Johanna Bendell, MD, director of GI Cancer Research Program, associate director, Drug Development Program, Sarah Cannon Research Institute, discusses a randomized phase III placebo-controlled trial that explored apatinib as a treatment for patients with advanced gastric cancer.

Dr. Bendell Discusses Two Studies in BRAF-Mutated CRC

June 02, 2014

Video

Johanna Bendell, MD, director of GI Cancer Research Program, associate director, Drug Development Program, Sarah Cannon Research Institute, discusses two studies in BRAF-mutated colorectal cancer.

Dr. Bendell on a Study of Onartuzumab Plus Bevacizumab for mCRC

May 13, 2014

Video

Johanna Bendell, MD, discusses the rationale of a phase II trial looking at onartuzumab (MetMAb) and bevacizumab for patients with metastatic colorectal cancer (mCRC).

Dr. Bendell on using OMP-59R5 to treat Pancreatic Cancer

February 21, 2014

Video

Johanna Bendell, MD, director of GI Cancer Research Program, associate director, Drug Development Program, Sarah Cannon Research Institute, discusses the anti-cancer stem cell antibody OMP-59R5 as a treatment option for patients with metastatic pancreatic cancer.

x